Literature DB >> 29332904

Detection of Fucoidan in Urine after Oral Intake of Traditional Japanese Seaweed, Okinawa mozuku (Cladosiphon okamuranus Tokida).

Yoshiharu Tokita1, Minami Hirayama1, Katsuyuki Nakajima1, Kenei Tamaki2, Masahiko Iha3, Takeaki Nagamine1.   

Abstract

Seaweed has been considered an indigestible food. Fucoidan, which is found abundantly in seaweed, especially in Cladosiphon okamuranus (Okinawa mozuku), has a high molecular weight and has been long believed to be hardly absorbed in the human digestive system due to a lack of certain digestive enzymes. We previously reported that fucoidan can be detected in serum and urine after oral intake of purified fucoidan in humans and rats. However, it is unclear whether the fucoidan in mozuku can be absorbed after digestion of mozuku. Therefore, we attempted to detect fucoidan in urine before and after mozuku intake. We determined the fucoidan concentration in urine after oral intake of Okinawa mozuku and urinary fucoidan was detected in several volunteers. In conclusion, these results suggest that fucoidan in mozuku can be absorbed after ingestion of mozuku.

Entities:  

Keywords:  Cladosiphon okamuranus (Okinawa mozuku); fucoidan; oral intake; urine

Mesh:

Substances:

Year:  2017        PMID: 29332904     DOI: 10.3177/jnsv.63.419

Source DB:  PubMed          Journal:  J Nutr Sci Vitaminol (Tokyo)        ISSN: 0301-4800            Impact factor:   2.000


  11 in total

Review 1.  Potential Beneficial Actions of Fucoidan in Brain and Liver Injury, Disease, and Intoxication-Potential Implication of Sirtuins.

Authors:  Jasmina Dimitrova-Shumkovska; Ljupcho Krstanoski; Leo Veenman
Journal:  Mar Drugs       Date:  2020-05-05       Impact factor: 5.118

2.  Absorption Study of Mozuku Fucoidan in Japanese Volunteers.

Authors:  Kizuku Kadena; Makoto Tomori; Masahiko Iha; Takeaki Nagamine
Journal:  Mar Drugs       Date:  2018-07-30       Impact factor: 5.118

3.  Evaluation of the Immunomodulatory Effects of Fucoidan Derived from Cladosiphon Okamuranus Tokida in Mice.

Authors:  Makoto Tomori; Takeaki Nagamine; Tomofumi Miyamoto; Masahiko Iha
Journal:  Mar Drugs       Date:  2019-09-24       Impact factor: 5.118

Review 4.  Therapies from Fucoidan: New Developments.

Authors:  Helen J Fitton; Damien S Stringer; Ah Young Park; Samuel N Karpiniec
Journal:  Mar Drugs       Date:  2019-10-09       Impact factor: 5.118

Review 5.  Pharmacokinetics of Marine-Derived Drugs.

Authors:  Alexander N Shikov; Elena V Flisyuk; Ekaterina D Obluchinskaya; Olga N Pozharitskaya
Journal:  Mar Drugs       Date:  2020-11-09       Impact factor: 5.118

6.  Evaluation of a Brown Seaweed Extract from Dictyosiphon foeniculaceus as a Potential Therapeutic Agent for the Treatment of Glioblastoma and Uveal Melanoma.

Authors:  Philipp Dörschmann; Christina Schmitt; Kaya Saskia Bittkau; Sandesh Neupane; Michael Synowitz; Johann Roider; Susanne Alban; Janka Held-Feindt; Alexa Klettner
Journal:  Mar Drugs       Date:  2020-12-08       Impact factor: 5.118

7.  Enhanced Cellular Uptake in an Electrostatically Interacting Fucoidan-L-Arginine Fiber Complex.

Authors:  Vinothini Arunagiri; Hsieh-Chih Tsai; Haile Fentahun Darge; Endiries Yibru Hanurry; Chang Yi Lee; Juin-Yih Lai; Szu-Yuan Wu
Journal:  Polymers (Basel)       Date:  2021-05-29       Impact factor: 4.329

8.  Oral Fucoidan Attenuates Lung Pathology and Clinical Signs in a Severe Influenza a Mouse Model.

Authors:  Claire Richards; Neil A Williams; J Helen Fitton; Damien N Stringer; Samuel S Karpiniec; Ah Young Park
Journal:  Mar Drugs       Date:  2020-05-08       Impact factor: 5.118

Review 9.  Brown Seaweeds for the Management of Metabolic Syndrome and Associated Diseases.

Authors:  Daniela Gabbia; Sara De Martin
Journal:  Molecules       Date:  2020-09-12       Impact factor: 4.411

10.  Fucoidan Independently Enhances Activity in Human Immune Cells and Has a Cytostatic Effect on Prostate Cancer Cells in the Presence of Nivolumab.

Authors:  Ah Young Park; Imane Nafia; Damien N Stringer; Samuel S Karpiniec; J Helen Fitton
Journal:  Mar Drugs       Date:  2021-12-22       Impact factor: 5.118

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.